Rebooting the Immune System With High-Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis

Annals of the New York Academy of Sciences - United States
doi 10.1196/annals.1405.033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Escalation Strategies in the Treatment of Refractory Myasthenia Gravis

Neurology International Open
2018English

Understanding the Burden of Refractory Myasthenia Gravis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2019English

Ephedrine Treatment for Autoimmune Myasthenia Gravis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2017English

Refractory Myasthenia Gravis: Clinical Description and Literature Review

Scholars Journal of Applied Medical Sciences
2020English

Refractory Myasthenia Gravis – Patient Burden and the Need for New Therapeutic Targets

European Neurological Review
Neurology
2018English

Employment in Refractory Myasthenia Gravis: An Mgfa Registry Analysis

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2019English

High Dose, Dose-Intensive Chemotherapy With Doxorubicin and Cyclophosphamide for the Treatment of Advanced Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy